retatrutide dosing trials ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial retatrutide dosing trial Reta clinical

demonstrated an improvement in menstrual cyclicity, as well as clinical and biochemical hyperandrogenism following 10-month supplementation with a botanical supplement containing Vitex agnus-castus (chasteberry) and DIM, in addition to acupuncture

Wu Y, Zhou BP

Barrier dysfunction in AD patients results from reduced expression of the filaggrin gene, ceramide deficiency and overexpression of epidermal proteases (1820)

Li, Y., Wang, Y., Wei, Q., Zheng, X., Tang, L., Kong, D., & Gong, M

Methodology L-carnitine (LC) has gained attention as a potential ergogenic aid, especially for athletes engaged in high-intensity and endurance sports

Provider experience and thoroughness differ widely